drugset / Trial / NCT00888628
Study of Islet Transplantation in Type 1 Diabetic Kidney Transplant Recipients
Phase 1/2
Completed
7 enrolled
Massachusetts General Hospital
Boston Area Diabetes Endocrinology Research Center (funded by NIDDK) · collab
NaSingle-groupOpen-labelTreatment
Summary
The purpose of the study is to learn if islet transplantation is an effective treatment for Type 1 diabetes in people who have had a kidney transplant. The primary objectives of the study are: \- To set up islet transplantation in patients who have had a kidney transplant and who are using an immunosuppressive regimen that works The Secondary objective of the study is: * To find out if successful islet transplantation leads to improved metabolic control and reduced renal complication from diabetes
Timeline
- Start
- 2009-05
- Primary completion
- 2014-08
- Completion
- 2016-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Purified Pancreatic Islets | Cell therapy | — | — |
| Background | Etanercept | Protein / enzyme biologic | — | — |